CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 1 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,000 | 0.0% | 377 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | -96.7% | 377 | -80.2% | 0.00% | – |
| Q4 2015 | $30,000 | +900.0% | 1,902 | +509.6% | 0.00% | – |
| Q3 2015 | $3,000 | -62.5% | 312 | 0.0% | 0.00% | – |
| Q2 2015 | $8,000 | -92.2% | 312 | -91.4% | 0.00% | – |
| Q1 2015 | $102,000 | -29.2% | 3,637 | -53.7% | 0.00% | -100.0% |
| Q4 2014 | $144,000 | +15.2% | 7,862 | -18.5% | 0.00% | 0.0% |
| Q3 2014 | $125,000 | -9.4% | 9,649 | +13.9% | 0.00% | 0.0% |
| Q2 2014 | $138,000 | -73.8% | 8,470 | -71.6% | 0.00% | -50.0% |
| Q1 2014 | $527,000 | -33.0% | 29,820 | -8.2% | 0.00% | -33.3% |
| Q4 2013 | $787,000 | +68.5% | 32,482 | +146.7% | 0.00% | +50.0% |
| Q3 2013 | $467,000 | +191.9% | 13,166 | +28.8% | 0.00% | +100.0% |
| Q2 2013 | $160,000 | – | 10,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TSP Capital Management Group, LLC | 813,273 | $3,286,000 | 1.66% |
| RTW INVESTMENTS, LP | 1,243,164 | $5,022,000 | 1.52% |
| Marcus Capital, LLC | 112,200 | $453,000 | 0.44% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 996,178 | $4,024,000 | 0.29% |
| Benchmark Capital Advisors | 67,000 | $271,000 | 0.20% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 360,299 | $1,456,000 | 0.20% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 2,907,523 | $11,746,000 | 0.15% |
| Virtus ETF Advisers LLC | 59,537 | $241,000 | 0.12% |
| Bellevue Group AG | 160,000 | $646,000 | 0.12% |
| PDT Partners, LLC | 428,300 | $1,730,000 | 0.10% |